Eridanus WhatsApp
Palce A Enqirey
Banner background

Paroxetine (Controlled Release) 12.5 mg + Clonazepam 0.5 mg

RUPATINE-CR PLUS Paroxetine CR Clonazepam Tablet pack – Eridanus Healthcare
RUPATINE-CR PLUS Paroxetine CR Clonazepam Tablet pack – Eridanus Healthcare
RUPATINE-CR PLUS Paroxetine CR Clonazepam Tablet visual aid – Eridanus Healthcare
Eridanus Healthcare
Tablet Range

RUPATINE-CR PLUS

Composition :

Paroxetine (Controlled Release) 12.5 mg + Clonazepam 0.5 mg

Packaging Type:

Box

Dimensions:

10*10 ALU ALU

Min Order Qty:

1

G. S. T (%)

5 %

Paroxetine CR 12.5mg and Clonazepam 0.5mg Tablets (RUPATINE-CR PLUS)

RUPATINE-CR PLUS contains Paroxetine 12.5mg (controlled release) + Clonazepam 0.5mg per tablet. It contains clonazepam, a psychotropic substance controlled under the NDPS Act, so it is handled as a restricted product. It is supplied only to licensed pharmacies, distributors and hospitals, against a valid drug licence and the documentation the law requires.

Not for sale to patients or for personal use. No online orders.

Product Specifications

  • Brand: RUPATINE-CR PLUS
  • Composition: Paroxetine 12.5mg (controlled release) + Clonazepam 0.5mg per tablet
  • Dosage form: Tablet
  • Pack: 10 x 10 Alu-Alu strip
  • Status: Contains clonazepam (NDPS Act psychotropic); prescription only
  • GST: 5%
  • Marketed by: Eridanus Healthcare

Supply Conditions

  • Available to licensed buyers on request only
  • Valid drug licence must be shared before supply
  • Rates and availability are shared only after licence verification

Licensed buyers can use Place Enquiry on this page. Our team will verify licences before sharing any details.

This information is for licensed pharmacies, distributors, hospitals and registered medical practitioners only. RUPATINE-CR PLUS is to be sold by retail only on the prescription of a Registered Medical Practitioner.